|
1. Juneja D, Nasa P, Chanchalani G, Cherian A, Jagiasi BG, Javeri Y, Kola VR, Kothekar AT, Kumar P, Maharaj M, Munjal M, Nandakumar SM, Nikalje A, Nongthombam R, Ray S, Sinha MK, Sodhi K, Myatra SN (2024). The Indian Society of critical care medicine position statement on the management of sepsis in resource-limited settings. Indian Journal of Critical Care Medicine. 28(Suppl 2): S4-S19.
2. Bhattacharya PK, Chakrabarti A, Sinha S, Pande R, Gupta S, Kumar AA, Mishra VK, Kumar S, Bhosale S, Reddy PK (2024). ISCCM position statement on the management of invasive fungal infections in the intensive care unit. Indian Journal of Critical Care Medicine. 28(Suppl 2):S20-S41.
3. Lonare A, Raychaudhuri K, Shah S, Madhu G, Sachdeva A, Basu S, Thorat R, Gupta S, Dalal SN (2024). 14-3-3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer. International Journal of Cancer.
4. Rahman MM, Rahman MS, Islam MR, Gilmour S, Haruyama R, Budukh A, Shankar A, Mishra G, Mehrotra R, Matsuda T, Inoue M, Abe SK (2024). Regional variations and inequalities in testing for early detection of breast and cervical cancer: evidence from a nationally representative survey in India. Journal of Epidemiology.
Thesis
1. Shreosi Chatterjee. 2024. Study of Size, Shape, and Dynamics of the Nucleolus. (LIFE09201604009)(Guide: Dr. Sorab Dalal)
Book Chapters
All below book chapters are appeared In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore.
1. Patkar N, Nathany S, Gudapati P, Mehta A, Chatterjee G, Kodgule R, Tembhare P, Subramanian PG, Gujral S (2024). Oncological Hematopathology. Pp.71-87.
2. Gota V, Nookala Krishnamurthy M, Patil A, Nehra J, Mehta PR (2024). Clinical Pharmacology in Oncology. Pp.199-212.
3. Dikshit R, Budukh A. (2024). Cancer Registration in India. Pp.229 -238.
4. Pimple SA, Mishra GA. (2024). Cancer Screening in India. Pp.239-250.
5. Punatar S, Shetty D. (2024). Adult Myeloproliferative Disorders/Myelodysplastic Syndromes/Overlap Syndromes. Pp. 283-290.
6. Tembhare P, Sastri GJ, Bagal B. (2024). Plasma Cell Dyscrasias. Pp. 291-305.
7. Epari, S., Narula, G. (2024). Histiocytic and Dendritic Cell Neoplasms. Pp. 319-330.
8. Bonda A, Khattry N. (2024). Hematopoietic Stem Cell Transplantation. Pp. 367-375.
9. Bhat KV, Jain H. (2024). Pediatric Myeloproliferative Disorders/Myelodysplastic Syndromes/Overlap Syndromes. Pp.359-365.
10. Moiyadi A, Singh V, Tonse R, Jalali R. (2024). Central Nervous System (CNS) Tumors. Pp. 379-404
11. Nair S, Wadasadawala T, Thakkar P, Kembhavi S, Bajpai J, Gulia S, Pathak R, Turkar S, Badwe R (2024). Breast Cancer. PP.451-470.
12. Sirohi B, Khobragade K, Patkar S, Ramaswamy A, Mondal M, Chopra S, D'Souza M, Goel M (2024). Biliary Tract Cancer. Pp.517-533.
13. Joshi A, Dholakia K, Bakshi G. (2024). Adrenocortical Carcinoma. Pp. 679-685.
14. Prakash G, Gupta AM, Sood S, Murthy V. (2024). Urinary Bladder Cancer. Pp. 687-706.
15. Joshi, A., Shrirangwar, S., Kataria, P., Goel, A., Pande, N. (2024). Testicular Cancer. Pp. 751-761.
16. Shylasree TS, Chopra S, Bansal R, Bhattacharjee A, Bajpai J. (2024). Vulvar and Vaginal Cancers. Pp.795-808.
17. Gulia S, Talreja V, Ghosh J, Gupta S, Bajpai J. (2024). Gestational Trophoblastic Disease. Pp.809-820.
18. Ghosh J, Maheshwari A, Rekhi B, Thakkar(Popat) P, Damani A, Poddar P, Mahantshetty U (2024).Epithelial Ovarian Cancer. Pp.821-846.
19. Ghosh J, Maheshwari A, Rekhi B, Thakkar (Popat) PB, Rath S, Kannan RA (2024). Non-Epithelial Ovarian Cancers. Pp. 847-855.
20. Sarin R. (2024). Hereditary Cancers. 1031-1045.
21. Thota RS, Jain P. (2024). Pain Management. Pp.983-993.
|
